Research Partnership to Focus on Telehealth Gambling Treatment
Playtech (LON: PTEC), a leading gambling technology company, and Kindbridge, the world’s first virtual mental health clinic for gamblers and gamers, have announced a new research partnership. The aim is to create an evidence-based model for gambling treatment in a telehealth setting.
The research partnership will be using advancements in technology to improve the understanding and treatment of gambling addiction. It will focus on the mental health of gamblers and those who suffer from digital dependency.
The Kindbridge Research Institute has commissioned the Center for Gambling Studies at Rutgers University in New Jersey to create the evidence-based telehealth model. It will be used to assess how effective various addiction treatments are. The data, which is set to be of a size and scale never seen before, will be used for peer-reviewed research.
By working with casino operators in the US, the Kindbridge Research Institute is seeking to provide gamblers with access to care through telehealth. Through data analysis, the aim is to define personalized intelligent approaches to treatment.
The research partnership with Kindbridge and Rutgers University will play a critical role in helping the sector design and deliver high-quality digital wellbeing and mental health support for those at-risk and affected by gambling-related harm. We are delighted to partner with Kindbridge Research Institute and Kindbridge clinical network as they pioneer the next generation of gambling treatment, services, and support in the U.S.
Daniel Umfleet, the CEO of Kindbridge, said that by combining data from players with Kindbridge’s clinical network, they would be able to gain “meaningful insight that has never before been achieved”. He added, “This research will allow data scientists, academics, and researchers to gain more insight on effective support and treatment in a digital environment than ever before.”
Lia Nower, J.D., Ph.D., Professor, and Director of the Center for Gambling Studies at Rutgers University, also welcomed the partnership. She explained that the ability to test the effectiveness of treatments “fills an unmet need in this time of rapid expansion”.